Western blot analysis from all B-cell lymphoma cell lines showed that BRD4, Myc and Bcl-2 protein expression was not altered following I-BET762 treatment over time (Figure 3f). This evidence concerns the gene BRD4 and B-cell non-Hodgkin lymphoma.